Green Tea Reduces Ovarian Cancer

A new research has brought about a remarkable discovery in the world of oncology, which says that women who drink tea are less likely to develop ovarian cancer than those women who do not drink tea.

The researchers have stated that the women who drink tea regularly have lower risk of developing ovarian cancer. In other words, if we take statistics, women who take at least 2 cups of tea per day have a 46 percent lower risk of ovarian cancer compared with non-tea drinkers and an each additional cup of tea is associated with an 18 percent lower risk of developing ovarian cancer.

It is also stated that both the green and black tea may protect against other different cancers. For this, the researchers conducted a study, which is described as follows:

The study was based on consumption of tea and the risk of ovarian cancer in more than 60,000 women who were aged 40 to 76.

The women were given out questionnaires to fill out, which were related to what beverages they take regularly and they have been taking for the past 15 years. The statistics that were collected showed that about two-thirds of the women said they drank tea at least once a month.

During the follow-up period there were about 301 women who were established with ovarian cancer and researchers found the link that tea drinking was associated with lowered ovarian cancer risk.

So the researchers found that the women who drank at least two cups of tea per day were half as likely to develop ovarian cancer as women who did not take tea than those who took at least 1 cup of tea a day had a 24 percent lower risk.

The study also showed that the women who take an additional cup of tea apart from the two cups have an additional 18 percent more reduction in ovarian cancer risk.

The data also suggests that black as well as green tea contains potent anticancer compounds. There are still more studies that are needed to confirm the relationship between tea and cancer so revolutionary steps can be taken in the prevention of ovarian cancer.


Leave a Reply